FODMAP-Targeting Enzyme Supplement Improves IBS Symptoms in Study
A commercially available digestive enzyme supplement targeting fermentable oligo-, di-, and monosaccharides, and polyols, or FODMAPs, significantly reduced irritable bowel syndrome symptom severity over a four-week prospective study presented at … Read More